Comparison of Analgesic Efficacy of PENB Block With FICB in Post Operative Hip Fracture Patients

Hip Fracture Surgery Clinical Trial

Official title:

Comparison of Analgesic Efficacy of Ultrasound Guided Pericapsular Nerve Group Block Versus Fascia Iliaca Compartment Block in Patients of Hip Fracture

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05810012
• Other study ID #: PENG vs FICB
• Status: Completed
• Phase: Phase 2
• Start date: April 1, 2022
• Est. completion date: October 31, 2022

Study information

• Verified date: March 2023
• Source: Pain Medicine Department
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study was done to evaluate two different interventions for postoperative pain control in patients undergoing hip surgeries. Fifty patients, divided in two equal groups, were included in the study. Patients in Group P were given pericapsular nerve group (PENG) block while those in Group F were given fascia iliaca compartment block (FICB). Pain score, using Numeric Rating scale as a measurement tool, was assessed at one, six, eighteen and twenty fours after the procedure as a primary outcome. Total tramadol consumption in milligrams was recorded as a secondary outcome.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: October 31, 2022
• Est. primary completion date: October 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 70 Years

Eligibility

Inclusion Criteria:

• surgical correction of fracture neck of femur under spinal anaesthesia

Exclusion Criteria:

• allergy to local anaesthetics

• bleeding disorders

• morbid obesity with BMI more than 35

• patients of chronic pain

• drug addiction

• psychiatric issues

Related Conditions & MeSH terms

• Fractures, Bone
• Hip Fracture Surgery
• Hip Fractures
• Pain, Postoperative
• Post-operative Pain Management

Intervention

Drug:
• PENG block
10ml of 0.125% isobaric bupivacaine injected
• FICB Block
20ml of 0.125% isobaric bupivacaine injected

Locations

Country	Name	City	State
Pakistan	Pain Medicine Department	Lahore

Sponsors (1)

Lead Sponsor	Collaborator
Pain Medicine Department

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain score using Numeric Rating scale	Pain scored assessed after completion of surgery at one, six, eighteen and twenty fours	24 hours
Secondary	Total Tramadol consumption	Total Tramadol consumption In twenty four hours	24 hours